Earnings Call · Q2 FY2026·2026-08-06

Q2 26EPS -100.00%*·Rev n/aQ1 26EPS -44.90%·Rev n/aQ4 25EPS 0.00%·Rev n/aQ3 25EPS -56.00%·Rev n/a⚠ consensus missing

Definium Therapeutics, Inc. DFTX

Geeta Jain — Head of Investor Relations

Rob Barrow — Chief Executive Officer

Dr. Dan Carlin — Chief Medical Officer

Matt Wiley — Chief Commercial Officer

Brandy Roberts — Chief Financial Officer

0.0%1d on move date3d−11.3%5d−4.9%

Research tier

Behavioral profile computed for 5 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more DFTX calls or request research access.

More DFTX calls Browse calls Request research access